Correlation of size and focality with prognosis in small breast carcinoma: a single institution case series.
Breast carcinoma
Microinvasive
Multifocality
Prognosis
Recurrence
Journal
Breast (Edinburgh, Scotland)
ISSN: 1532-3080
Titre abrégé: Breast
Pays: Netherlands
ID NLM: 9213011
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
24
07
2020
revised:
06
10
2020
accepted:
14
10
2020
pubmed:
26
10
2020
medline:
4
8
2021
entrez:
25
10
2020
Statut:
ppublish
Résumé
The clinical behavior and prognosis of small multifocal and microinvasive breast cancers are still debated together with the best method of assessing tumor size in multiple invasive carcinomas. This study evaluates the clinico-pathological features of single and multiple breast cancers up to 0.5 cm in order to evaluate the rate of recurrences. We retrospectively analyzed 170 node-negative patients consecutively treated at European Institute of Oncology from 2001 to 2006. We divided them into Group I (pT1mi) and Group II (pT1a) furtherly divided in subgroups, according to focality and aggregate diameter. For each group we assessed tumor size, (multi)focality, extensive in situ component (EIC), histology, grade, peritumoral vascular invasion (PVI), hormonal receptor status (HR), HER-2 expression, Ki67 expression. We observed that the frequency of local recurrences and distant metastases in group I was higher among those with a single focus; whereas in group II, it was higher in multifocal carcinomas. Then, by comparing the two groups, the prognosis was better in multiple pT1mi than in similarly sized unifocal pT1a. Microinvasive carcinomas are associated with a good prognosis, even if they seem to have a more aggressive intrinsic biological behavior. Multifocality seems to be correlated with a worse prognosis in case of invasive carcinomas pT1a. In case of microinvasive carcinomas, by contrast, multifocality per se does not seem to affect the recurrence rate.
Identifiants
pubmed: 33099081
pii: S0960-9776(20)30197-1
doi: 10.1016/j.breast.2020.10.006
pmc: PMC7581961
pii:
doi:
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
164-169Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declarations of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Cancer Biol Med. 2016 Mar;13(1):142-9
pubmed: 27144069
Breast. 2012 Oct;21(5):682-5
pubmed: 22835917
Cancer. 2013 Mar 15;119(6):1132-9
pubmed: 23279980
Ann Surg Oncol. 2014 Oct;21(10):3330-5
pubmed: 25092160
J Clin Oncol. 2018 Jul 10;36(20):2105-2122
pubmed: 29846122
JAMA. 2004 Apr 28;291(16):1972-7
pubmed: 15113815
Cancer. 2002 Mar 1;94(5):1383-90
pubmed: 11920492
Arch Pathol Lab Med. 2009 Oct;133(10):1515-38
pubmed: 19792042
J Natl Cancer Inst. 2006 Nov 1;98(21):1571-81
pubmed: 17077359
Hum Pathol. 2011 Nov;42(11):1761-9
pubmed: 21663941
J Am Coll Surg. 2012 Jul;215(1):137-46; discussion 146-7
pubmed: 22608402
Ann Surg Oncol. 2012 Oct;19(11):3395-401
pubmed: 22476758
Histopathology. 1991 Nov;19(5):403-10
pubmed: 1757079
Breast Cancer. 2013 Oct;20(4):331-5
pubmed: 22396321
BMC Cancer. 2013 Jul 26;13:361
pubmed: 23890049
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e581-6
pubmed: 22208975
Am J Surg. 2000 Oct;180(4):305-8
pubmed: 11113441
Cancer. 1982 Oct 1;50(7):1309-14
pubmed: 6286091
Ann Surg Oncol. 2013 Mar;20(3):811-8
pubmed: 22956068